Positron

What Positron does

Positron Corporation (OTCMKTS: POSC) is a U.S.-based medical technology company founded around 1983–1985 and headquartered in Niagara Falls, New York, with an operational presence in Fishers, Indiana. It develops and sells PET and PET-CT molecular imaging systems purpose-built for nuclear cardiology, with secondary applicability in oncology and neurology. Its product portfolio centers on the Attrius PET (a dedicated cardiac PET scanner with proprietary cardiac software, 30-minute stress/rest protocol, and a compact 15' x 20' footprint) and the NeuSight PET-CT 64-Slice Scanner (a hybrid system with 72cm wide-bore gantry, proprietary IPIE position identification, proprietary respiratory gating, and AI-powered image reconstruction). An upcoming Affinity PET-CT 4D 64-Slice scanner is in development.

The company monetizes through one-time capital sales of PET-CT scanners, bundled multi-year service agreements, and rental/lease-to-own financing programs, supplemented by clinical services including training, physician interpretation support, and billing assistance. Go-to-market is primarily direct enterprise field sales to nuclear cardiology practices and hospitals, augmented by an industry partnership with MedAxiom (announced October 2025) that provides access to a nationwide cardiovascular network. Geographic focus is North America, with stated plans and active CE marking efforts to enter European and Canadian markets.

Operationally, Positron is an early-stage public company. FY2025 net loss exceeded $10M, Q1 2026 revenue was $110,000, and the company has raised approximately $10M in equity in 2025 ($8M in March, $2M in December) on top of a $59.46M market capitalization as of April 2026. It maintains an R&D venture with Shenyang Intelligent Neuclear Technology Co. for technology development. The company reports a headcount of 51–100 employees.

Name

Positron

Legal name

Positron Corporation

Website

https://positron.com

Company type

Public

Founded year

1985

Operating status

Operating

Headcount range

51–100 employees

Short description

Positron Corporation (OTCMKTS: POSC) develops and sells PET and PET-CT molecular imaging systems, primarily the Attrius PET and NeuSight PET-CT 64-Slice scanner, for nuclear cardiology practices, hospitals, and oncology and neurology imaging centers, monetizing through capital sales, multi-year service agreements, and rental/lease-to-own programs.

Ownership category

akta.pro rank

Product category

Medical Imaging Systems

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

Keywords

• Molecular imaging systems
• PET-CT scanners
• Nuclear cardiology
• Cardiac PET imaging
• Medical imaging devices

Headquarters

HQ city

North Tonawanda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

1. PET-CT Scanner Sales: Sale of NeuSight PET-CT 64-slice scanners to nuclear cardiology practices and healthcare facilities. Each sale includes associated long-term service agreements.
2. Service Agreements: Long-term service agreements bundled with scanner sales, providing ongoing maintenance, support, and software upgrades.
3. Rental and Lease-to-Own Programs: Unique rental and lease-to-own programs making advanced diagnostic tools accessible to practices of all sizes.
4. Clinical Services and Support: Comprehensive clinical services including training, technical support, physician interpretation, and billing assistance.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Positron Corporation designs, manufactures, and sells PET and PET-CT molecular imaging systems, including the NeuSight PET-CT 64-Slice Scanner and the Attrius PET dedicated cardiac scanner. The company also delivers comprehensive clinical services such as training, technical support, physician interpretation assistance, and billing support, and offers flexible rental and lease-to-own financing to healthcare providers.

Product overview

Positron Corporation offers a portfolio of PET and PET-CT imaging systems for nuclear medicine. The core products include the Attrius PET (dedicated cardiac PET scanner) and NeuSight PET-CT 64-slice scanner (hybrid imaging system for cardiac, oncology, and neurology). The upcoming Affinity PET-CT 4D 64-Slice Scanner will expand capabilities to both cardiac and oncology imaging. The company also provides comprehensive clinical services including physician interpretation training, nurse training, billing support, and prior-authorization assistance, alongside MedAxiom partnership for market access and CE marking efforts for European market expansion.

Differentiator

Problem solved

Functional benefit

Brands

• Attrius PET: Dedicated cardiac PET scanner for nuclear cardiac PET imaging offering high-quality imaging at an affordable price with features including stress/rest protocol, compact footprint, and proprietary cardiac software.
• NeuSight PET-CT
• Affinity PET-CT

Products and services

• NeuSight PET-CT 64-Slice Scanner Advanced PET-CT 3D 64-slice scanner with a 72cm wide-bore gantry, high-sensitivity detector technology, AI-powered image reconstruction, proprietary respiratory gating, and a compact footprint. Designed for cardiac, oncology, and neurology imaging applications for healthcare providers and imaging centers.
• Attrius PET Dedicated cardiac PET scanner with a compact footprint (fits in a 15' x 20' area), proprietary cardiac-specific software, 30-minute stress/rest protocol, 440-pound table capacity, integrated INTEL chipset with 7-second reconstruction times per image set, and low cost of ownership. For nuclear cardiology practices and cardiac imaging centers.
• Clinical Services and Support Comprehensive clinical services including physician interpretation training, nurse training, technical support, billing support, and prior-authorization assistance for healthcare providers using Positron's PET and PET-CT systems.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Shenyang Intelligent Neuclear Technology Co.minorStrategic or Co-development Partner · 17 February 2026Positron maintains an R&D venture with Shenyang Intelligent Neuclear Technology Co. for advancing PET imaging technology. This collaboration represents Positron's technology development efforts including development of the NeuSight PET-CT 3D 64-slice scanner launched in July 2024.
• MedAxiomcoreStrategic or Co-development Partner · 2 October 2025Positron entered into an industry partnership agreement with MedAxiom, a cardiovascular performance solutions organization. Through this partnership, Positron gains access to MedAxiom's nationwide network of cardiovascular organizations, physicians, and clinicians to advance adoption of its PET imaging technology. The collaboration provides market intelligence, clinical insights, and opportunities to expand Positron's user base and accelerate adoption of cardiac imaging solutions.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Spectrum Dynamics Medical: Specializes in dedicated cardiac nuclear imaging systems (e.g., D-SPECT) and is one of the closest direct peers to Positron in the cardiac molecular imaging niche, competing for the same nuclear cardiology practices.
• Mediso Medical Imaging Systems: Smaller, specialized PET/PET-CT manufacturer with strong nuclear medicine heritage, similar in profile to Positron as a focused PET-OEM targeting cardiology, oncology, and neurology imaging markets.
• Digirad Corporation: Provides mobile cardiac nuclear imaging services and smaller footprint solid-state SPECT; comparable to Positron as a small-cap nuclear cardiology operator with similar customer segments and a service-style business model.

Broad incumbents

• Hitachi Healthcare (FUJIFILM Healthcare): Provides PET and SPECT imaging systems (SceptreP series and SCENARIA) for cardiology and oncology, making it a relevant modality-incumbent peer in nuclear cardiology installations.
• GE HealthCare: Broad incumbent offering PET, PET-CT, SPECT, and integrated imaging suites globally with a much larger installed base and capital budget than Positron; the most direct large-OEM competitor in PET-CT for cardiac, oncology, and neurology applications.
• Siemens Healthineers: Major PET-CT vendor selling the Biograph family of scanners with deep cardiology/oncology/nuclear medicine reach and entrenched service contracts — Positron's most direct head-to-head in the cardiac PET replacement cycle.
• Philips: Operates in molecular imaging through its Philips Healthcare division with PET/CT offerings and global hospital channel relationships, competing for the same cardiology and oncology imaging dollars as Positron.
• Canon Medical Systems: Sells PET-CT scanners and a full diagnostic imaging portfolio (formerly Toshiba Medical) to hospitals and imaging centers, providing multi-modality procurement alternatives Positron must compete against.

Emerging players

• Cubresa: Focused PET insert developer for clinical and preclinical imaging; adjacent to Positron's molecular imaging franchise and useful as a comparable for AI-driven PET technology innovation.
• United Imaging Healthcare: Fast-growing Chinese imaging OEM offering competitively priced PET-CT, MRI, and CT systems with global expansion; comparable to Positron as a newer modality entrant but with broader product breadth and aggressive pricing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/positron-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Positron